These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22431439)

  • 1. Pregabalin augmentation of antidepressants in older patients with comorbid depression and generalized anxiety disorder-an open-label study.
    Karaiskos D; Pappa D; Tzavellas E; Siarkos K; Katirtzoglou E; Papadimitriou GN; Politis A
    Int J Geriatr Psychiatry; 2013 Jan; 28(1):100-5. PubMed ID: 22431439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability.
    Montgomery S; Emir B; Haswell H; Prieto R
    Curr Med Res Opin; 2013 Oct; 29(10):1223-30. PubMed ID: 23808960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study.
    Dobrea C; Buoli M; Arici C; Camuri G; Dell'Osso B; Altamura AC
    Expert Opin Drug Saf; 2012 Nov; 11(6):893-9. PubMed ID: 22946673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT; Clary CM
    Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms.
    Olivares JM; Álvarez E; Carrasco JL; Pérez Páramo M; López-Gómez V
    Int Clin Psychopharmacol; 2015 Sep; 30(5):265-71. PubMed ID: 26111356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label trial of nefazodone in high comorbidity panic disorder.
    DeMartinis NA; Schweizer E; Rickels K
    J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study.
    Pae CU; Marks DM; Han C; Masand PS; Patkar AA
    Int Clin Psychopharmacol; 2009 Jan; 24(1):29-33. PubMed ID: 19060720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of pregabalin in generalized anxiety disorder.
    Feltner D; Wittchen HU; Kavoussi R; Brock J; Baldinetti F; Pande AC
    Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM; Boyce E; Guyer J; Nuzum D
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety associated with comorbid depression.
    Möller HJ
    J Clin Psychiatry; 2002; 63 Suppl 14():22-6. PubMed ID: 12562115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin for the treatment of generalized anxiety disorder.
    Wensel TM; Powe KW; Cates ME
    Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbid depression and anxiety spectrum disorders.
    Gorman JM
    Depress Anxiety; 1996-1997; 4(4):160-8. PubMed ID: 9166648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of pregabalin and sertraline in complex treatment of patients with partial epilepsy comorbid with depressive and anxiety disorders].
    Bondarenko II; Kissin MIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):29-36. PubMed ID: 22951778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of persistence of comorbid generalized anxiety disorder among veterans with major depressive disorder.
    Mittal D; Fortney JC; Pyne JM; Wetherell JL
    J Clin Psychiatry; 2011 Nov; 72(11):1445-51. PubMed ID: 21208594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of generalized anxiety disorder in patients with depressive symptomatology.
    Rickels K; Schweizer E
    J Clin Psychiatry; 1993 Jan; 54 Suppl():20-3. PubMed ID: 8093885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.
    Bandelow B; Wedekind D; Leon T
    Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
    J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.
    Feltner DE; Crockatt JG; Dubovsky SJ; Cohn CK; Shrivastava RK; Targum SD; Liu-Dumaw M; Carter CM; Pande AC
    J Clin Psychopharmacol; 2003 Jun; 23(3):240-9. PubMed ID: 12826986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.